Andrew P Suckling is Director of 180 Life Sciences Corp.. Currently has a direct ownership of 149,020 shares of ATNF, which is worth approximately $359,138. The most recent transaction as insider was on Nov 14, 2025, when has been sold 149,020 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 149K
n/a 3M change
n/a 12M change
Total Value Held $359,138

ANDREW P SUCKLING Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 14 2025
SELL
Bona fide gift
-
149,020 Reduced 50.0%
149,020 Common Stock
Nov 12 2025
SELL
Payment of exercise price or tax liability
-
175,854 Reduced 27.06%
473,894 Common Stock
Nov 12 2025
BUY
Grant, award, or other acquisition
-
649,748 Added 50.0%
649,748 Common Stock

Also insider at

BOXS
BOXSCORE BRANDS, INC. Basic Materials
APS

Andrew P Suckling

Director
New York, NY

Track Institutional and Insider Activities on ATNF

Follow 180 Life Sciences Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATNF shares.

Notify only if

Insider Trading

Get notified when an 180 Life Sciences Corp. insider buys or sells ATNF shares.

Notify only if

News

Receive news related to 180 Life Sciences Corp.

Track Activities on ATNF